These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 713245)
1. [Pathogenesis of blood coagulation disorders in coronary arteriosclerosis]. Ermolaev VV; Sytnikova IA Kardiologiia; 1978 Oct; 18(10):132-3. PubMed ID: 713245 [No Abstract] [Full Text] [Related]
2. [Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart]. Furkalo NK; Dukhina MA; Bol'shakova RM; SolovtsovA KM; Progonnaia Kardiologiia; 1976 Dec; 16(12):32-40. PubMed ID: 1011479 [TBL] [Abstract][Full Text] [Related]
3. [Changes in the hemostatic system in patients with ischemic heart disease after isovolemic hemodilution]. Liusov VA; Soboleva VN; Katyshkina NI Kardiologiia; 1985 Sep; 25(9):63-7. PubMed ID: 4079228 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure]. Panchenko EP Kardiologiia; 1981 Aug; 21(8):50-5. PubMed ID: 7289383 [TBL] [Abstract][Full Text] [Related]
5. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818 [TBL] [Abstract][Full Text] [Related]
6. [Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis]. Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G Riv Crit Clin Med; 1968; 68(3):211-37. PubMed ID: 5737876 [No Abstract] [Full Text] [Related]
7. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Lowe GD; Rumley A; McMahon AD; Ford I; O'Reilly DS; Packard CJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1529-34. PubMed ID: 15205218 [TBL] [Abstract][Full Text] [Related]
8. [Studies of thrombophilic syndromes. II. Preliminary research on the behavior of the plasmatic inhibitor of the product of the contact reaction in coronary, cerebral and peripheral arteriosclerosis]. Neri Serneri GG; Paoletti P; Silvestrini E; Masotti G Riv Crit Clin Med; 1968; 68(4):289-323. PubMed ID: 5746286 [No Abstract] [Full Text] [Related]
9. [Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease]. Andreenko GV; Panchenko VM; Lisina AN; Liutova LV Kardiologiia; 1978 Oct; 18(10):57-60. PubMed ID: 713256 [TBL] [Abstract][Full Text] [Related]
10. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease]. Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000 [TBL] [Abstract][Full Text] [Related]
19. [Quantitative immunoenzyme method for determining fibrin-fibrinogen degradation products in the blood]. Ermolin GA; Liusov VA; Panchenko EP Lab Delo; 1984; (1):11-5. PubMed ID: 6199554 [No Abstract] [Full Text] [Related]
20. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease]. Pliutto AM Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365 [No Abstract] [Full Text] [Related] [Next] [New Search]